A smaller group is profoundly affected
Check dates on everything
The primary focus, as we've noted, is often on metabolic improvements
Eur J Med Res 30(1):260 [DOI] [PMC free article] [PubMed] [Google Scholar] 62.Rooks D, Praestgaard J, Hariry S, Laurent D, Petricoul O, Perry RG et al (2017) Treatment of sarcopenia with bimagrumab: results from a phase II, Randomized, Controlled, Proof-of-Concept study
Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
This post is for general informational purposes only and is not intended as legal or other professional advice